Login / Signup
CS12192, a novel JAK3/JAK1/TBK1 inhibitor, attenuates autoimmune dermatoses in murine models.
Dan Li
Song Shan
Xuhua Mao
Yiru Zhao
Beizhong Chen
Qiuyun Xiong
Desi Pan
Shengjian Huang
Published in:
Immunopharmacology and immunotoxicology (2024)
Our findings suggest that the novel JAK3/JAK1/TBK1 inhibitor CS12192 is potentially to alleviate autoimmune dermatosis.
Keyphrases
</>
multiple sclerosis
drug induced